Pyridine

Pyridine

SCHEMBL28296779

O=[Cr](=O)O.c1ccncc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAPRT Q6XQN6 3/20 0.60
▸ TSHR P16473 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.33
▸ APP P05067 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HCAR3 P49019 1/20 0.33
▸ HCAR2 Q8TDS4 1/20 0.33
▸ TAAR1 Q96RJ0 1/20 0.31
▸ PLOD2 O00469 1/20 0.31
▸ PLOD3 O60568 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ PLOD1 Q02809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL29358144 0.86 NAPRT (0.69) NAPRTTSHRTDP1MEN1KMT2A
Pyridine SCHEMBL1536 0.86 NAPRT (0.69) NAPRTTSHRTDP1MEN1KMT2A
Pyridine SCHEMBL27285374 0.83 TSHR (0.64) NAPRTTSHRTDP1MEN1KMT2A
Pyridine SCHEMBL30472691 0.82 — —
Pyridine SCHEMBL28067297 0.82 NAPRT (0.90) NAPRTTSHRTDP1MEN1KMT2A
Pyridine SCHEMBL30984419 0.82 TSHR (0.90) NAPRTTSHRTDP1MEN1KMT2A
Pyridine SCHEMBL1685618 0.82 — —
Pyridine SCHEMBL6532110 0.82 — —
Pyridine SCHEMBL28297010 0.82 — —
Pyridine SCHEMBL5278800 0.79 NAPRT (0.69) NAPRTTSHRTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109803962-A Modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions, methods of treatment, and methods for making the modulators 弗特克斯药品有限公司 2019-05-24 — — CN disclosed
Send feedback